Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 2/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.45 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.45 |
| ▸ | PGK1 | P00558 | 5/20 | 0.44 |
| ▸ | PGK2 | P07205 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9174132 | 0.90 | ACP3 (0.57) | ACP3GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL4287643 | 0.83 | ACP3 (0.55) | ACP3GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL578080 | 0.77 | SMN1; SMN2 (0.57) | ACP3PGK1PGK2SMN1; SMN2CES2 | |
| SCHEMBL29707862 | 0.75 | ACP3 (0.65) | ACP3GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL8053801 | 0.75 | ACP3 (0.65) | ACP3GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL5795783 | 0.73 | RIPK1 (0.38) | RIPK1PIN1 | |
| SCHEMBL112270 | 0.72 | CES2 (0.43) | CES2BCHECES1RIPK1 | |
| SCHEMBL266645 | 0.72 | RIPK1 (0.49) | CES2BCHECES1RIPK1 | |
| SCHEMBL424618 | 0.72 | CES2 (0.43) | CES2BCHECES1RIPK1 | |
| SCHEMBL2957481 | 0.72 | CES2 (0.43) | CES2BCHECES1RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10985446-B1 | Physically reconfigurable structurally embedded vascular antenna and method of making | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2021-04-20 | — | — | US | claimed |
| US-10944178-B1 | Physically reconfigurable structurally embedded vascular antenna | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2021-03-09 | — | — | US | claimed |
| US-10129975-B1 | Liquid metal interfaces for flexible and reconfigurable electronics | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2018-11-13 | — | — | US | claimed |
| US-20250334727-A1 | OPTICAL FILTER, OPTICAL DEVICE, AND LIGHT-ABSORBING COMPOSITION | NIPPON SHEET GLASS CO LTD (JP) | 2025-10-30 | — | — | US | disclosed |
| US-20250231329-A1 | LIGHT-ABSORBING COMPOSITION, LIGHT-ABSORBING FILM, AND OPTICAL FILTER | NIPPON SHEET GLASS CO LTD (JP) | 2025-07-17 | — | — | US | disclosed |
| US-12313869-B2 | Optical filter, optical device, and light-absorbing composition | NIPPON SHEET GLASS COMPANY, LIMITED (JP) | 2025-05-27 | — | — | US | disclosed |
| US-12287501-B2 | Light-absorbing composition, light-absorbing film, and optical filter | NIPPON SHEET GLASS COMPANY, LIMITED (JP) | 2025-04-29 | — | — | US | disclosed |
| US-12071542-B2 | Light-absorbing composition and optical filter | NIPPON SHEET GLASS COMPANY, LIMITED (JP) | 2024-08-27 | — | — | US | disclosed |
| US-20240192414-A1 | LAMINATE, VISUAL-LINE TRACKING SYSTEM, AND HEAD-MOUNTED DISPLAY | FUJIFILM CORPORATION (JP) | 2024-06-13 | — | — | US | disclosed |
| US-20230400615-A1 | OPTICAL FILTER, OPTICAL DEVICE, AND LIGHT-ABSORBING COMPOSITION | NIPPON SHEET GLASS COMPANY, LIMITED (JP) | 2023-12-14 | — | — | US | disclosed |
| US-20230322793-A1 | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1 ',2':4,5]pyrazino[1,2-B]pyridazine-3,5-dione Derivatives and Related Compounds as Inhibitors of the Orthomyxovirus Replication for Treating Influenza | NOVARTIS AG (CH) | 2023-10-12 | — | — | US | disclosed |
| US-10129975-B1 | Liquid metal interfaces for flexible and reconfigurable electronics | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2018-11-13 | — | — | US | disclosed |
| US-10129975-B1 | Liquid metal interfaces for flexible and reconfigurable electronics | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2018-11-13 | — | — | US | disclosed |
| US-9939727-B2 | Method for manufacturing patterned object, patterned object, and light irradiation apparatus | USHIO DENKI KABUSHIKI KAISHA (JP) | 2018-04-10 | — | — | US | disclosed |
| US-20170052447-A1 | METHOD FOR MANUFACTURING PATTERNED OBJECT, PATTERNED OBJECT, AND LIGHT IRRADIATION APPARATUS | USHIO DENKI KABUSHIKI KAISHA (JP) | 2017-02-23 | — | — | US | disclosed |
| US-20050014732-A1 | Combination of an aldosterone receptor antagonist and an anti-diabetic agent | PHARMACIA CORPORATION (US) | 2005-01-20 | — | — | US | disclosed |
| US-6572986-B2 | Subjecting the phosphor, the organic phosphorus compound, and a polyurethane binder to dispersing processing in order to prepare a coating mixture, applying the coating on a substrate to form phoshor layer | FUJI PHOTO FILM CO., LTD. (JP) | 2003-06-03 | — | — | US | disclosed |
| US-20010053461-A1 | Radiation image storage panel and process for producing the same | FUJIFILM CORPORATION (JP) | 2001-12-20 | — | — | US | disclosed |
| US-6099895-A | PHOSPHONIC ACID SURFACE MODIFYING COMPOUND | IMATION CORP. (US) | 2000-08-08 | — | — | US | disclosed |
| US-5868959-A | MAGNETIC PIGMENT HAVING ARALKYL PHOSPHONIC ACID ADSORBED ONTO SURFACE; HIGH SATURATION MAGNETIZATION AND HIGH SURFACE AREA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014732-A1 | Combination of an aldosterone receptor antagonist and an anti-diabetic agent | NR3C2, REN, AGTR1 | ACP3 1586/4885GRIN2D 3548/4885GRIN3B 2822/4885 |
| US-20230322793-A1 | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1 ',2':4,5]pyrazino[1,2-B]pyridazine-3,5-dione Derivatives and Related Compounds as Inhibitors of the Orthomyxovirus Replication for Treating Influenza | MAVS, ZC3HAV1, EIF2AK2 | ACP3 4417/4885GRIN2D 4105/4885GRIN3B 4130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.